Actinomycosis: a frequently forgotten disease

L Boyanova, R Kolarov, L Mateva, R Markovska… - Future …, 2015 - Future Medicine
Actinomycosis is a rare subacute or chronic, endogenous infection mainly by Actinomyces
species, showing low virulence through fimbriae and biofilms. Cervicofacial, thoracic …

Geographic map and evolution of primary Helicobacter pylori resistance to antibacterial agents

L Boyanova, I Mitov - Expert Review of Anti-Infective Therapy, 2010 - Taylor & Francis
Antibiotic resistance in Helicobacter pylori is the major cause of eradication failure. Primary
H. pylori susceptibility patterns, however, are becoming less predictable. Currently, high (≥ …

Recent evolution of antibiotic resistance in the anaerobes as compared to previous decades

L Boyanova, R Kolarov, I Mitov - Anaerobe, 2015 - Elsevier
Evolution of antibiotic resistance in the anaerobes was reviewed using recent data covering
2000–2013 as compared to previous years. All studies reported growing moxifloxacin …

Activity of Bulgarian propolis against 94 Helicobacter pylori strains in vitro by agar-well diffusion, agar dilution and disc diffusion methods

L Boyanova, G Gergova, R Nikolov… - Journal of medical …, 2005 - microbiologyresearch.org
Propolis exhibits antimicrobial, anti-inflammatory and other biological effects. The aim of this
study was to evaluate the activity of 30% ethanolic extract of Bulgarian propolis against 94 …

European Registry on Helicobacter pylori management (Hp-EuReg): patterns and trends in first-line empirical eradication prescription and outcomes of 5 years and 21 …

OP Nyssen, D Bordin, B Tepes, Á Pérez-Aisa, D Vaira… - Gut, 2021 - gut.bmj.com
Objective The best approach for Helicobacter pylori management remains unclear. An audit
process is essential to ensure clinical practice is aligned with best standards of care. Design …

[HTML][HTML] Evolution of Helicobacter pylori Resistance to Antibiotics: A Topic of Increasing Concern

L Boyanova, P Hadzhiyski, R Gergova, R Markovska - Antibiotics, 2023 - mdpi.com
Antibiotic resistance among Helicobacter pylori strains is the major cause of eradication
failure. Resistance prevalence is dynamic and can greatly vary among countries over the …

Multidrug resistance in Helicobacter pylori: current state and future directions

L Boyanova, P Hadzhiyski, N Kandilarov… - Expert review of …, 2019 - Taylor & Francis
Introduction: Helicobacter pylori antibiotic resistance has increased worldwide and multidrug
resistance (MDR), which seriously hampers eradication success of the frequent chronic …

Stress hormone epinephrine (adrenaline) and norepinephrine (noradrenaline) effects on the anaerobic bacteria

L Boyanova - Anaerobe, 2017 - Elsevier
Microbial endocrinology is a relatively new research area that already encompasses the
anaerobes. Stress hormones, epinephrine and norepinephrine, can affect the growth of …

The status of antimicrobial resistance of Helicobacter pylori in eastern Europe

L Boyanova, A Mentis, M Gubina… - Clinical Microbiology …, 2002 - Wiley Online Library
Objective To evaluate the primary, secondary and combined resistance to five antimicrobial
agents of 2340 Helicobacter pylori isolates from 19 centers in 10 countries in eastern …

Prevalence and evolution of Helicobacter pylori resistance to 6 antibacterial agents over 12 years and correlation between susceptibility testing methods

L Boyanova, G Gergova, R Nikolov, L Davidkov… - … and infectious disease, 2008 - Elsevier
The aim of this study was to evaluate Helicobacter pylori antibacterial resistance in 2005 to
2007, resistance evolution since 1996 to 1999, and performance of breakpoint susceptibility …